flecainide has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 22 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the electrophysiological effects of intravenous propafenone and flecainide on accessory pathway conduction by a randomized crossover study in 16 patients with Wolff-Parkinson-White syndrome." | 9.07 | A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. ( Camm, AJ; Garratt, CJ; Gill, J; Linker, NJ; O'Nunain, S; Ward, DE, 1991) |
| "The effects of flecainide on electrophysiologic parameters and arrhythmias in the Wolff-Parkinson-White syndrome were reviewed." | 8.78 | Flecainide in the Wolff-Parkinson-White syndrome. ( Crozier, I, 1992) |
| "We compared the electrophysiological effects of intravenous propafenone and flecainide on accessory pathway conduction by a randomized crossover study in 16 patients with Wolff-Parkinson-White syndrome." | 5.07 | A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. ( Camm, AJ; Garratt, CJ; Gill, J; Linker, NJ; O'Nunain, S; Ward, DE, 1991) |
| "Eighty-three patients with paroxysmal supraventricular tachycardia (Wolff-Parkinson-White syndrome in 47 patients and atrioventricular nodal reentry in 36 patients) underwent electrophysiologic study before and after intravenous administration of flecainide." | 5.06 | Long-term efficacy and safety of flecainide for supraventricular tachycardia. ( Neuss, H; Schlepper, M, 1988) |
| "The effects of flecainide on electrophysiologic parameters and arrhythmias in the Wolff-Parkinson-White syndrome were reviewed." | 4.78 | Flecainide in the Wolff-Parkinson-White syndrome. ( Crozier, I, 1992) |
| "Flecainide is effective in terminating stable atrial flutter in the conscious dog with a Y-shaped right atrial lesion." | 3.68 | Endocardial mapping of reentry around an anatomical barrier in the canine right atrium: observations during the action of the Class IC agent, flecainide. ( Boyden, PA; Graziano, JN; Pinto, JM, 1993) |
| "1) Flecainide treatment prolonged HV and VA intervals, and the addition of isoproterenol did not affect these variables." | 2.67 | Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide. ( Griffin, JC; Helmy, I; Herre, JM; Scheinman, MM; Sharkey, H, 1990) |
| "It may cause a reentry circuit." | 2.43 | [Atrioventricular nodal reentry tachycardia in children]. ( Greve, G; Hoff, PI; Mikkelsen, RB; Vislie, CH, 2006) |
| " Little justification for the use of agents or dosing in children is available." | 2.40 | Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. ( Kuhn, RJ; Luedtke, SA; McCaffrey, FM, 1997) |
| "A 16 year old female with tricuspid atresia had undergone a Fontan operation at four years of age." | 1.30 | Iatrogenic atrioventricular bypass tract following a Fontan operation for tricuspid atresia. ( Bostock, J; Gill, J; Rosenthal, E, 1997) |
| "Oral flecainide was effective in a small number of infants, with no adverse effects (95% CI 0% to 12%), and may now be preferred as the primary prophylactic agent." | 1.29 | Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants? ( Gardiner, HM; O'Sullivan, JJ; Wren, C, 1995) |
| "Oral flecainide therapy was effective in 33 of 63 patients who had tachycardia and an extranodal accessory connection." | 1.28 | Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. ( Cockrell, JL; Griffin, JC; Helmy, I; Langberg, JJ; Lee, MA; Scheinman, MM; Titus, C, 1991) |
| "Flecainide acetate was administered to 19 patients who had inducible sustained orthodromic atrioventricular reentrant tachycardia." | 1.27 | Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia. ( Kim, SS; Ruffy, R; Zee-Cheng, CS, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 13 (59.09) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Ciriello, GD | 1 |
| Colonna, D | 1 |
| Papaccioli, G | 1 |
| Correra, A | 1 |
| Romeo, E | 1 |
| Palladino, MT | 1 |
| Cioppa, ND | 1 |
| Russo, MG | 1 |
| Sarubbi, B | 1 |
| Uzun, O | 1 |
| Babaoglu, K | 1 |
| Sinha, A | 1 |
| Massias, S | 1 |
| Beattie, B | 1 |
| Kanemoto, M | 1 |
| Shimizu, A | 1 |
| Yamagata, T | 1 |
| Esato, M | 1 |
| Ueyama, T | 1 |
| Yoshiga, Y | 1 |
| Kakugawa, H | 1 |
| Kametani, R | 1 |
| Inoue, N | 1 |
| Sawa, A | 1 |
| Matsuzaki, M | 1 |
| Vislie, CH | 1 |
| Mikkelsen, RB | 1 |
| Hoff, PI | 2 |
| Greve, G | 1 |
| O'Sullivan, JJ | 1 |
| Gardiner, HM | 1 |
| Wren, C | 1 |
| Gutiérrez-Larraya, F | 1 |
| Jabón, A | 1 |
| Mannino, MM | 1 |
| Mehta, D | 1 |
| Gomes, JA | 1 |
| Pinto, JM | 1 |
| Graziano, JN | 1 |
| Boyden, PA | 1 |
| Rosenthal, E | 1 |
| Bostock, J | 1 |
| Gill, J | 2 |
| Luedtke, SA | 1 |
| Kuhn, RJ | 1 |
| McCaffrey, FM | 1 |
| Danse, PW | 1 |
| Garratt, CJ | 2 |
| Mast, F | 1 |
| Allessie, MA | 1 |
| Crozier, I | 1 |
| Musto, B | 1 |
| Cavallaro, C | 1 |
| Musto, A | 1 |
| D'Onofrio, A | 1 |
| Belli, A | 1 |
| De Vincentis, L | 1 |
| Kulakowski, P | 1 |
| Gibson, S | 1 |
| Ward, J | 1 |
| Camm, AJ | 3 |
| O'Nunain, S | 1 |
| Linker, NJ | 1 |
| Ward, DE | 1 |
| Cockrell, JL | 1 |
| Scheinman, MM | 2 |
| Titus, C | 1 |
| Helmy, I | 2 |
| Langberg, JJ | 1 |
| Lee, MA | 1 |
| Griffin, JC | 2 |
| Bashir, Y | 1 |
| Herre, JM | 1 |
| Sharkey, H | 1 |
| Till, JA | 1 |
| Rowland, E | 1 |
| Shinebourne, EA | 1 |
| Zee-Cheng, CS | 1 |
| Kim, SS | 1 |
| Ruffy, R | 1 |
| Neuss, H | 1 |
| Schlepper, M | 1 |
| Tronstad, A | 1 |
| Oie, B | 1 |
| Ohm, OJ | 1 |
4 reviews available for flecainide and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
[Atrioventricular nodal reentry tachycardia in children].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Catheter Ablation; Child; Child, Preschool; Electric Coun | 2006 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp | 1993 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Ch | 1997 |
Flecainide in the Wolff-Parkinson-White syndrome.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Flecainide; Heart Conduction Syst | 1992 |
4 trials available for flecainide and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Flecainide; Humans; Male; Propafenon | 1991 |
Clinical trials of flecainide acetate in the management of supraventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Flecainide; Humans; | 1990 |
Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
Topics: Cardiac Pacing, Artificial; Electrophysiology; Flecainide; Heart Conduction System; Humans; Isoprote | 1990 |
Long-term efficacy and safety of flecainide for supraventricular tachycardia.
Topics: Cardiac Pacing, Artificial; Clinical Trials as Topic; Electrocardiography; Electrophysiology; Flecai | 1988 |
14 other studies available for flecainide and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Flecainide; Humans; Infant; Infant, Newborn; Propranolol; Tachyc | 2023 |
Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Therapy, Combination; Echoc | 2012 |
Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, C | 2004 |
Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants?
Topics: Anti-Arrhythmia Agents; Digoxin; Drug Administration Schedule; Flecainide; Humans; Infant; Infant, N | 1995 |
Current treatment options for paroxysmal supraventricular tachycardia.
Topics: Acute Disease; Catheter Ablation; Chronic Disease; Flecainide; Humans; Propafenone; Tachycardia, Atr | 1994 |
Endocardial mapping of reentry around an anatomical barrier in the canine right atrium: observations during the action of the Class IC agent, flecainide.
Topics: Animals; Atrial Flutter; Atrial Function; Dogs; Endocardium; Flecainide; Heart Conduction System; Ta | 1993 |
Iatrogenic atrioventricular bypass tract following a Fontan operation for tricuspid atresia.
Topics: Adolescent; Anti-Arrhythmia Agents; Catheter Ablation; Combined Modality Therapy; Female; Flecainide | 1997 |
Preferential depression of conduction around a pivot point in rabbit ventricular myocardium by potassium and flecainide.
Topics: Animals; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Cardiac Pacing, Artificial; Cathete | 2000 |
Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
Topics: Administration, Oral; Adolescent; Cardiac Pacing, Artificial; Child; Female; Flecainide; Follow-Up S | 1992 |
Flecainide-related alterations in the signal-averaged electrocardiogram: similarity between patients with or without ventricular tachycardia.
Topics: Electrocardiography; Female; Flecainide; Heart Ventricles; Humans; Infusions, Intravenous; Male; Mid | 1992 |
Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Child; Electric Stimulation; | 1991 |
Use of flecainide in children.
Topics: Child; Child, Preschool; Flecainide; Humans; Infant; Tachycardia, Atrioventricular Nodal Reentry; Ta | 1989 |
Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
Topics: Adult; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Flecainide; Follo | 1988 |
Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Electrophysiology; Female; Flecainide; Humans; | 1988 |